These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2554350)

  • 21. Evidence for distinct calcium channel agonist and antagonist binding sites in intact cultured embryonic chick ventricular cells.
    Lee RT; Smith TW; Marsh JD
    Circ Res; 1987 May; 60(5):683-91. PubMed ID: 2439230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM; Bladen C
    Biochemistry; 1991 Jun; 30(23):5716-21. PubMed ID: 1645998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Calcium alters the properties of [3H]diazepam binding sites in rat brain membranes.
    Wu PH; Phillis JW
    Int J Biochem; 1986; 18(4):345-50. PubMed ID: 3011535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioligand and functional estimates of the interaction of the 1,4-dihydropyridines, isradipine and lacidipine, with calcium channels in smooth muscle.
    Salomone S; Godfraind T
    Br J Pharmacol; 1993 May; 109(1):100-6. PubMed ID: 8495233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [3H]PN200-110 binding in a fibroblast cell line transformed with the alpha 1 subunit of the skeletal muscle L-type Ca2+ channel.
    Rampe D; Kim HS; Lacerda AE; Birnbaumer L; Brown AM
    Biochem Biophys Res Commun; 1990 Jun; 169(3):825-31. PubMed ID: 2163635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temperature-dependent modulation of [3H]nitrendipine binding by the calcium channel antagonists verapamil and diltiazem in rat brain synaptosomes.
    Boles RG; Yamamura HI; Schoemaker H; Roeske WR
    J Pharmacol Exp Ther; 1984 May; 229(2):333-9. PubMed ID: 6716261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization.
    Liu J; Bangalore R; Rutledge A; Triggle DJ
    Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. gamma-Aminobutyric acid release from synaptosomes as influenced by Ca2+ and Ca2+ channel blockers.
    Carvalho CM; Santos SV; Carvalho AP
    Eur J Pharmacol; 1986 Nov; 131(1):1-12. PubMed ID: 3816939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S; Kimura R; Harada Y; Nakayama K
    J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competitive inhibition of [3H]spiperone binding to D-2 dopamine receptors in striatal homogenates by organic calcium channel antagonists and polyvalent cations.
    De Vries DJ; Beart PM
    Eur J Pharmacol; 1984 Oct; 106(1):133-9. PubMed ID: 6241565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depression of calcium channel blocker binding to rat brain membranes by halothane.
    Drenger B; Heitmiller ES; Quigg M; Blanck TJ
    Anesth Analg; 1992 May; 74(5):758-61. PubMed ID: 1314528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of oxygen free radicals on calcium current and dihydropyridine binding sites in guinea-pig ventricular myocytes.
    Guerra L; Cerbai E; Gessi S; Borea PA; Mugelli A
    Br J Pharmacol; 1996 Jul; 118(5):1278-84. PubMed ID: 8818354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries.
    Bression D; Chaumet-Riffaud P; Brandi AM; Comte A; Peillon F; Kiechel JR
    Mol Cell Endocrinol; 1987 Apr; 50(3):255-61. PubMed ID: 3032711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells.
    Kunze DL; Hamilton SL; Hawkes MJ; Brown AM
    Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic relevance of dihydropyridine binding sites in membranes from rat aorta: kinetic and equilibrium studies.
    Wibo M; DeRoth L; Godfraind T
    Circ Res; 1988 Jan; 62(1):91-6. PubMed ID: 2446799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.
    Gu XH; Dillon JS; Nayler WG
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):272-8. PubMed ID: 2464098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dihydropyridine-sensitive Ca2+ channel in aneurally cultured human muscles. Relationship between high-affinity binding site and inhibition of calcium uptake.
    Desnuelle C; Askanas V; Engel WK
    FEBS Lett; 1988 Mar; 230(1-2):95-100. PubMed ID: 2450788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of Ca2+ channel blockers on Ca2+ translocation across synaptosomal membranes.
    Carvalho CA; Coutinho OP; Carvalho AP
    J Neurochem; 1986 Dec; 47(6):1774-84. PubMed ID: 2430061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional dihydropyridine binding site associated with slow calcium channel in rat cultured neurones.
    Maloteaux JM; Octave JN; Laterre EC
    Neurosci Lett; 1988 Apr; 87(1-2):168-72. PubMed ID: 2454427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (+)-PN200-110 and ouabain binding sites in purified bovine adrenomedullary plasma membranes and chromaffin cells.
    Castillo CJ; Fonteríz RI; López MG; Rosenheck K; García AG
    J Neurochem; 1989 Nov; 53(5):1442-9. PubMed ID: 2529351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.